Dana Sambarino
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Modeling hepatitis D virus kinetics during bulevirtide monotherapy: challenges and solutions.
Journal: ArXiv
Published: June 12, 2026
Mathematical modeling of HDV RNA, HBsAg, and ALT kinetics in patients with compensated cirrhosis: Insights from 96 Weeks of bulevirtide monotherapy.
Journal: Antiviral research
Published: May 20, 2026
HDV RNA Undetectability Rates During Bulevirtide Monotherapy in Patients With Chronic Hepatitis Delta May Be Assay Dependent.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: April 09, 2026
Baseline HDV-RNA Levels Could Stratify Clinical Risk Before, But Not After, Cirrhosis in Chronic Hepatitis D: A Multicentre European Study.
Journal: Alimentary pharmacology & therapeutics
Published: January 15, 2026
Dysregulated transcription in core- and pol-specific CD8 T cells can be targeted by HDAC inhibition to improve T-cell function in chronic hepatitis B.
Journal: Journal of hepatology
Published: July 28, 2025
Transcriptional and functional HBV-specific CD8 T cell changes from disease to functional cure in HBeAg-negative chronic hepatitis B.
Journal: JHEP reports : innovation in hepatology
Published: July 08, 2025
Course and clinical outcomes of chronic hepatitis delta: a longitudinal analysis of 565 patients from the D-SOLVE and HDV-1000 consortia.
Journal: Gut
Published: July 04, 2025
HBsAg Isoforms as Innovative Biomarkers in Predicting Virological Response to Bulevirtide in Patients With Chronic Hepatitis D.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: May 31, 2024
Differential HBV RNA and HBcrAg patterns in untreated patients with chronic hepatitis delta.
Journal: Journal of hepatology
Published: May 05, 2024
Comparing methods for plasma HDV RNA quantification in bulevirtide-treated and untreated patients with HDV.
Journal: JHEP reports : innovation in hepatology
Published: April 23, 2024
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis B.
Journal: Gut
Published: February 27, 2024
Dynamics of HBV biomarkers during nucleos(t)ide analog treatment: A 14-year study.
Journal: Hepatology communications
Published: February 01, 2024
Last Updated: 09/26/2026